Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus

References

• Araújo JE, Gonzalez-Mira MA, Egea ML, et al. (2010). Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm 393:168–76
   Web of Science ®Google Scholar
• Barnwell SG, Laudanski T, Story MJ, et al. (1992). Improved oral bioavailability of propranolol in healthy human volunteers using a liver bypass drug delivery system containing oleic acid. Int J Pharm 88:423–32
   Web of Science ®Google Scholar
• Das S, Ng WK, Tan RH. (2012). Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139–51
   PubMed Web of Science ®Google Scholar
• Haeri A, Sadeghian S, Rabbani S, et al. (2013). Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes. Int J Pharm 455:320–30
   PubMed Web of Science ®Google Scholar
• Hu X, Lin C, Chen D, et al. (2012). Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm 438:123–33
   PubMed Web of Science ®Google Scholar
• Hu X, Zhang J, Yu Z, et al. (2015). Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers. Nanomedicine 11:1939–48
   PubMed Web of Science ®Google Scholar
• Ibrahim F, Gershkovich P, Sivak O, et al. (2012). Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model. Eur J Pharm Sci 46:323–8
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim JS, Cho W, et al. (2013). Supersaturatable formulations for the enhanced oral absorption of sirolimus. Int J Pharm 445:108–16
   PubMed Web of Science ®Google Scholar
• Kubiak DW, Koo S, Hammond SP, et al. (2012). Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants. Biol Blood Marrow Transplant 18:1462–5
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang L, Zhao Y, et al. (2014). Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Int J Pharm 476:169–77
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–8
   PubMed Web of Science ®Google Scholar
• MacDonald A, Scarola J, Burke JT, et al. (2000). Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 22:B101–21
   PubMed Web of Science ®Google Scholar
• McEwan P, Baboolal K, Conway P, et al. (2005). Evaluation of the cost-effectiveness of Sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom. Clin Ther 27:1834–46
   PubMed Web of Science ®Google Scholar
• Moreno-Bautista G, Tam KC. (2011). Evaluation of dialysis membrane process for quantifying the in vitro drug-release from colloidal drug carriers. Colloid Surf A: Physicochem Eng Asp 389:299–303
   Web of Science ®Google Scholar
• Mu H, Holm R, Müllertz A. (2013). Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm 453:215–24
   PubMed Web of Science ®Google Scholar
• Mu H, Høy CE. (2004). The digestion of dietary triacylglycerols. Prog Lipid Res 43:105–33
   PubMed Web of Science ®Google Scholar
• O’Driscoll CM. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 15:405–15
   PubMed Web of Science ®Google Scholar
• Porter CJH, Charman WN. (2001). In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev 50:S127–47
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter CJH. (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev S 60:625–37
   PubMed Web of Science ®Google Scholar
• Rouf MA, Bilensoy E, Vural İ, et al. (2007). Inclusion complexation of rapamycin with beta-cyclodextrin to improve solubility and stability of the drug. Eur J Pharm Sci 32:S46–7
   Google Scholar
• Shangguan M, Lu Y, Qi J, et al. (2014). Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin. J Biomater Appl 28:887–96
   PubMed Web of Science ®Google Scholar
• Shangguan M, Qi J, Lu Y, et al. (2015). Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure. Int J Pharm 489:195–202
   PubMed Web of Science ®Google Scholar
• Simamora P, Alvarez JM, Yalkowsky SH. (2001). Solubilization of rapamycin. Int J Pharm 213:25–9
   PubMed Web of Science ®Google Scholar
• Solymosi T, Angi R, Basa Dénes O, et al. (2015). Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method. Eur J Pharm Biopharm 94:135–40
   PubMed Web of Science ®Google Scholar
• Sun M, Zhai X, Xue K, et al. (2011). Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci 43:132–40
   PubMed Web of Science ®Google Scholar
• Tian Z, Yi Y, Yuan H, et al. (2013). Solidification of nanostructured lipid carriers (NLCs) onto pellets by fluid-bed coating: preparation, in vitro characterization and bioavailability in dogs. Powder Technol 247:120–7
   Web of Science ®Google Scholar
• Watson CJE, Bradley JA. (2006). Sirolimus and everolimus: inhibitors of mammalian target of rapamycin in liver transplantation. Transplant Rev 20:104–14
   Google Scholar
• Wissing SA, Kayser O, Müller RH. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–72
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma PX. (2013). Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev 65:1215–33
   PubMed Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, et al. (2010). Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 394:179–85
   PubMed Web of Science ®Google Scholar